MiMedx Group is a biopharmaceutical company, develops, and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. MiMedx Group's proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications, OrthoFlo, an amniotic fluid-derived allograft for homologous applications, Physio, a bone grafting material comprising 100% bone tissue with no added carrier, and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. It also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue, AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process, and AmnioFill, a cellular tissue matrix allograft that enhances healing. MiMedX Group's products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. It sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group began operation on February 28, 2008. It has its headquarters in Marietta in Georgia.The staff at MiMedx come from unusually diverse demographic backgrounds. The company is 55.2% female and 50.6% ethnic minorities. Despite its diversity in other areas, MiMedx employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Republican Party, at 87.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Republican Party. MiMedx has great employee retention with staff members usually staying with the company for 4.6 years.MiMedx is a medium health care company with 690 employees and an annual revenue of $348.9M that is headquartered in Marietta, GA.
MiMedx's mission statement
To improve patient lives and elevate the standard of care in multiple sectors of healthcare.
In demand companies are hiring! Let Zippia apply for you!
The founders of MiMedx are Martin P. Sutter and Parker Petit.
The key people at MiMedx are Timothy R. Wright, Martin P. Sutter and Parker Petit.
Key people
Timothy R. Wright
Martin P. Sutter
Parker Petit
MiMedx rankings
MiMedx is ranked #23 on the Best Health Care companies to work for in Georgia list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
We calculated MiMedx’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of MiMedx’s workforce.
MiMedx diversity summary. Zippia estimates MiMedx's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated MiMedx's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of MiMedx's workforce.
MiMedx has 690 employees.
55% of MiMedx employees are women, while 45% are men.
The most common ethnicity at MiMedx is White (49%).
21% of MiMedx employees are Black or African American.
16% of MiMedx employees are Hispanic or Latino.
The average employee at MiMedx makes $60,683 per year.
MiMedx employees are most likely to be members of the republican party.
Employees at MiMedx stay with the company for 4.6 years on average.
Do you work at MiMedx?
Does MiMedx actively promote diversity and inclusion?
MiMedx financial performance
9.0
Performance score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
MiMedx currently has 267.8M in revenue. MiMedx's most recent quarter produced 81.7m (q3'2023).
MiMedx annual revenue
$349M
$279M
$209M
$140M
$70M
$0
2019
2020
2021
2022
2023
2024
Highest paying MiMedx competitors
Compare MiMedx salaries to competitors, including Johnson & Johnson, TissueTech, and SpineSmith. Employees at Johnson & Johnson earn the highest average yearly salary of $76,686. The salaries at TissueTech average $72,907 per year, and the salaries at SpineSmith come in at $71,194 per year.
Rank
Company
Average salary
Jobs
1
$76,686
0
2
$72,907
0
3
$71,194
0
4
$64,919
0
5
$62,385
0
6
$61,555
0
7
$60,486
0
8
$54,541
0
9
$54,368
0
10
$53,785
0
Show more
Are you an executive, HR leader, or brand manager at MiMedx?
Claiming and updating your company profile on Zippia is free and easy.
Zippia gives an in-depth look into the details of MiMedx, including salaries, political affiliations, employee data, and more, in order to inform job seekers about MiMedx. The employee data is based on information from people who have self-reported their past or current employments at MiMedx. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by MiMedx. The data presented on this page does not represent the view of MiMedx and its employees or that of Zippia.
MiMedx may also be known as or be related to MIMEDX GROUP INC., MIMEDX GROUP, INC., MIMEDX Group Inc, MiMedx, MiMedx Group, MiMedx Group Inc, MiMedx Group, Inc., Mimedx and Mimedx Group, Inc.